Table of Contents
International Journal of Molecular Imaging
Volume 2011, Article ID 796025, 15 pages
http://dx.doi.org/10.1155/2011/796025
Review Article

Molecular SPECT Imaging: An Overview

1Biological Imaging Centre, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK
2Nuclear Medicine Section, Medical Imaging Department, King Fahad Specialist Hospital, P.O. Box 11757, Dammam 31463, Saudi Arabia

Received 1 August 2010; Accepted 5 February 2011

Academic Editor: Hiroshi Watabe

Copyright © 2011 Magdy M. Khalil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. K. Von Schulthess and H. P. W. Schlemmer, “A look ahead: PET/MR versus PET/CT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, supplement 1, pp. S3–S9, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. M. A. Pysz, S. S. Gambhir, and J. K. Willmann, “Molecular imaging: current status and emerging strategies,” Clinical Radiology, vol. 65, no. 7, pp. 500–516, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Douraghy and A. F. Chatziioannou, “Preclincal imaging,” in Basic Sciences of Nuclear Medicine, M. Khalil, Ed., chapter 18, Springer, New York, NY, USA, 2011. View at Google Scholar
  4. M. E. Phelps, “PET: the merging of biology and imaging into molecular imaging,” Journal of Nuclear Medicine, vol. 41, no. 4, pp. 661–681, 2000. View at Google Scholar · View at Scopus
  5. S. R. Meikle, P. Kench, M. Kassiou, and R. B. Banati, “Small animal SPECT and its place in the matrix of molecular imaging technologies,” Physics in Medicine and Biology, vol. 50, no. 22, pp. R45–R61, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. G. K. Von Schulthess and T. F. Hany, “Imaging and PET—PET/CT imaging,” Journal de Radiologie, vol. 89, no. 3, pp. 438–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. O. Anger, “Scintillation camera,” Review of Scientific Instruments, vol. 29, no. 1, pp. 27–33, 1958. View at Publisher · View at Google Scholar · View at Scopus
  8. F. D. Van Have, B. Vastenhouw, R. M. Ramakers et al., “U-SPECT-II: an ultra-high-resolution device for molecular small-animal imaging,” Journal of Nuclear Medicine, vol. 50, no. 4, pp. 599–605, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. R. Stickel, J. Qi, and S. R. Cherry, “Fabrication and characterization of a 0.5-mm lutetium oxyorthosilicate detector array for high-resolution PET applications,” Journal of Nuclear Medicine, vol. 48, no. 1, pp. 115–121, 2007. View at Google Scholar · View at Scopus
  10. A. Sanchez-Crespo, P. Andreo, and S. A. Larsson, “Positron flight in human tissues and its influence on PET image spatial resolution,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 1, pp. 44–51, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. A. Ruangma, B. Bai, J. S. Lewis et al., “Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides,” Nuclear Medicine and Biology, vol. 33, no. 2, pp. 217–226, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. R. Palmer, X. Zhu, and J. A. Parker, “Modeling and simulation of positron range effects for high resolution PET imaging,” IEEE Transactions on Nuclear Science, vol. 52, no. 5, pp. 1391–1395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Gambhir, D. S. Berman, J. Ziffer et al., “A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera,” Journal of Nuclear Medicine, vol. 50, no. 4, pp. 635–643, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. Erlandsson, K. Kacperski, D. Van Gramberg, and B. F. Hutton, “Performance evaluation of D-SPECT: a novel SPECT system for nuclear cardiology,” Physics in Medicine and Biology, vol. 54, no. 9, pp. 2635–2649, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. L. Chen, Y. Wang, J. J. S. Lee, and B. M. W. Tsui, “Toward quantitative small animal pinhole SPECT: assessment of quantitation accuracy prior to image compensations,” Molecular Imaging and Biology, vol. 11, no. 3, pp. 195–203, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. A. B. Hwang, B. L. Franc, G. T. Gullberg, and B. H. Hasegawa, “Assessment of the sources of error affecting the quantitative accuracy of SPECT imaging in small animals,” Physics in Medicine and Biology, vol. 53, no. 9, pp. 2233–2252, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. B. L. Franc, P. D. Acton, C. Mari, and B. H. Hasegaway, “Small-animal SPECT and SPECT/CT: important tools for preclinical investigation,” Journal of Nuclear Medicine, vol. 49, no. 10, pp. 1651–1663, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. T. Funk, P. Després, W. C. Barber, K. S. Shah, and B. H. Hasegawa, “A multipinhole small animal SPECT system with submillimeter spatial resolution,” Medical Physics, vol. 33, no. 5, pp. 1259–1268, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Nuyts, K. Vunckx, M. Defrise, and C. Vanhove, “Small animal imaging with multi-pinhole SPECT,” Methods, vol. 48, no. 2, pp. 83–91, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. http://www.gm-ideas.com/pre_triumph_trimodality_system.html.
  21. http://www.milabs.com/.
  22. A. Del Guerra and N. Belcari, “State-of-the-art of PET, SPECT and CT for small animal imaging,” Nuclear Instruments and Methods in Physics Research A, vol. 583, no. 1, pp. 119–124, 2007. View at Publisher · View at Google Scholar
  23. J. Peter and W. Semmler, “Performance investigation of a dual-modality SPECT/optical small animal imager,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, p. S117, 2006. View at Google Scholar
  24. E. Breton, P. Choquet, C. Goetz et al., “Dual SPECT/MR imaging in small animal,” Nuclear Instruments and Methods in Physics Research A, vol. 571, no. 1-2, pp. 446–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. E. L. Ritman, “Molecular imaging in small animals—roles for micro-CT,” Journal of Cellular Biochemistry, no. 39, pp. 116–124, 2002. View at Google Scholar · View at Scopus
  26. S. J. Schambach, S. Bag, L. Schilling, C. Groden, and M. A. Brockmann, “Application of micro-CT in small animal imaging,” Methods, vol. 50, no. 1, pp. 2–13, 2010. View at Publisher · View at Google Scholar · View at PubMed
  27. C. Nichol and E. E. Kim, “Molecular imaging and gene therapy,” Journal of Nuclear Medicine, vol. 42, no. 9, pp. 1368–1374, 2001. View at Google Scholar · View at Scopus
  28. F. G. Blankenberg and H. W. Strauss, “Nuclear medicine applications in molecular imaging,” Journal of Magnetic Resonance Imaging, vol. 16, no. 4, pp. 352–361, 2002. View at Publisher · View at Google Scholar · View at PubMed
  29. S. Vallabhajosula, Molecular Imaging, Radiopharmaceuticals for PET and SPECT, Springer, New York, NY, USA, 2009.
  30. D. Maclean, J. P. Northrop, H. C. Padgett, and J. C. Walsh, “Drugs and probes: the symbiotic relationship between pharmaceutical discovery and imaging science,” Molecular Imaging and Biology, vol. 5, no. 5, pp. 304–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. G. B. Saha, Fundamentals of Radiopharmacy, Springer, Berlin, Germany, 5th edition, 2004.
  32. G. Kohler and C. Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature, vol. 256, no. 5517, pp. 495–497, 1975. View at Google Scholar · View at Scopus
  33. C. Schiepers, Diagnostic Nuclear Medicine, Springer, Berlin, Germany, 2nd edition, 2006.
  34. D. J. Hnatowich, “Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium,” Seminars in Nuclear Medicine, vol. 20, no. 1, pp. 80–91, 1990. View at Google Scholar · View at Scopus
  35. R. T. Maguire, V. L. Pascucci, A. N. Maroli, and J. V. Gulfo, “Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer: results with site-specific immunoconjugates,” Cancer, vol. 72, no. 11, pp. 3453–3462, 1993. View at Google Scholar · View at Scopus
  36. A. Otte, “Y90-Ibritumomab tiuxetan: new drug, interesting concept, and encouraging in practice,” Nuclear Medicine Communications, vol. 27, no. 7, pp. 595–596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Han, A. H. Iagaru, H. J. Zhu, and M. L. Goris, “Experience with Y90-ibritumomab (zevalin) in the management of refractory non-Hodgkin's lymphoma,” Nuclear Medicine Communications, vol. 27, no. 12, pp. 1022–1023, 2006. View at Google Scholar
  38. Immunomedics Europe Product monograph for the CEA-Scan (Arcitumomab) kit for the preparation of Tc-99m CEA-Scan, Immunomedics Europe, Darmstadt, Germany, 2000.
  39. F. L. Moffat Jr., C. M. Pinsky, L. Hammershaimb et al., “Immunomedics study group clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectumml: results of a pivotal, phase III trial,” Journal of Clinical Oncology, vol. 14, pp. 2295–2305, 1996. View at Google Scholar
  40. Immunomedics Europe Product monograph for LeukoScan (sulesomab), Immunomedics Europe, Darmstadt, Germany, 1997.
  41. S. Gratz, M. L. Schipper, J. Dörner et al., “LeukoScan for imaging infection in different clinical settings: a retrospective evaluation and extended review of the literature,” Clinical Nuclear Medicine, vol. 28, no. 4, pp. 267–276, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. F. G. Blankenberg, P. D. Katsikis, J. F. Tait et al., “Imaging of apoptosis (programmed cell death) with T99mc annexin V,” Journal of Nuclear Medicine, vol. 40, no. 1, pp. 184–191, 1999. View at Google Scholar · View at Scopus
  43. J. F. Tait, M. D. Cerqueira, T. A. Dewhurst, K. Fujikawa, J. L. Ritchie, and J. R. Stratton, “Evaluation of annexin V as a platelet-directed thrombus targeting agent,” Thrombosis Research, vol. 75, no. 5, pp. 491–501, 1994. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Ha, R. Mansberg, D. Nguyen, and C. Bui, “Increased activity on In-111 octreotide imaging due to radiation fibrosis,” Clinical Nuclear Medicine, vol. 33, no. 1, pp. 46–48, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. L. K. Kvols and E. A. Woltering, “Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors,” Anti-Cancer Drugs, vol. 17, no. 6, pp. 601–608, 2006. View at Publisher · View at Google Scholar · View at PubMed
  46. C. Susini and L. Buscail, “Rationale for the use of somatostatin analogs as antitumor agents,” Annals of Oncology, vol. 17, no. 12, pp. 1733–1742, 2006. View at Publisher · View at Google Scholar · View at PubMed
  47. I. Virgolini, I. Szilvasi, A. Kurtaran et al., “Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients,” Journal of Nuclear Medicine, vol. 39, no. 11, pp. 1928–1936, 1998. View at Google Scholar · View at Scopus
  48. D. Kahn, Y. Menda, K. Kernstine et al., “The utility of T99mc-depreotide compared with F-18-fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer,” Chest, vol. 125, no. 2, pp. 494–501, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Danielsson, M. Bååth, L. Svensson, U. Forslöv, and K.-G. Kölbeck, “Imaging of regional lymph node metastases with T99mc-depreotide in patients with lung cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 8, pp. 925–931, 2005. View at Publisher · View at Google Scholar · View at PubMed
  50. Berlex Laboratories Product Monograph for the NeoTect Kit for the Preparation of Tc-99m Depreotide, Berlex Laboratories, Wayne, NJ, USA, 2001.
  51. C. Henry, F. Koumanov, C. Ghezzi et al., “Experimental models, protocols, and reference values for evaluation of iodinated analogues of glucose,” Nuclear Medicine and Biology, vol. 22, no. 7, pp. 875–885, 1995. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Dumas, R. Schibli, and P. A. Schubigert, “Versatile routes to C-2- and C-6-functionalized glucose derivatives of iminodiacetic acid,” Journal of Organic Chemistry, vol. 68, no. 2, pp. 512–518, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. C. Dumas, J. Petrig, R. Schibli et al., “Functionalisation of glucose for the labeling with T99mc-tricarbonyl,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 44, pp. S57–S59, 2001. View at Google Scholar
  54. K. Kawai, Y. Fujibayashi, H. Saji et al., “A strategy for the study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-Iodo-alpha-methyl-L-tyrosine,” Journal of Nuclear Medicine, vol. 32, no. 5, pp. 819–824, 1991. View at Google Scholar · View at Scopus
  55. K. J. Langen, H. H. Coenen, N. Roosen et al., “SPECT studies of brain tumors wirh L-3-[I123]iodo-α-methyl tyrosine: comparison with PET, 124IMT and first clinical results,” Journal of Nuclear Medicine, vol. 31, no. 3, pp. 281–286, 1990. View at Google Scholar · View at Scopus
  56. K. J. Langen, N. Roosen, H. H. Coenen et al., “Brain and brain tumor uptake of L-3-[I123]iodo-α-methyl tyrosine: competition with natural L-amino acids,” Journal of Nuclear Medicine, vol. 32, no. 6, pp. 1225–1229, 1991. View at Google Scholar · View at Scopus
  57. J. G. Tjuvajev, M. Doubrovin, T. Akhurst et al., “Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression,” Journal of Nuclear Medicine, vol. 43, no. 8, pp. 1072–1083, 2002. View at Google Scholar · View at Scopus
  58. F. M. Bengel, M. Anton, T. Richter et al., “Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer,” Circulation, vol. 108, no. 17, pp. 2127–2133, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. K. A. Krohn, J. M. Link, and R. P. Mason, “Molecular imaging of hypoxia,” Journal of Nuclear Medicine, vol. 49, no. 6, pp. 129S–148S, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. J. R. Ballinger, “Imaging hypoxia in tumors,” Seminars in Nuclear Medicine, vol. 31, no. 4, pp. 321–329, 2001. View at Google Scholar · View at Scopus
  61. S. K. Technetium, Chemistry and Radiopharmaceutical Applications, Wiley-VCH, Weinheim, Germany, 2000.
  62. D. Stypinski, S. A. McQuarrie, L. I. Wiebe, Y. K. Tam, J. R. Mercer, and A. J. B. McEwan, “Dosimetry estimations for I123-IAZA in healthy volunteers,” Journal of Nuclear Medicine, vol. 42, no. 9, pp. 1418–1423, 2001. View at Google Scholar · View at Scopus
  63. P. A. Thomas and B. Mullan, “Avid In-111 labeled WBC accumulation in a patient with active osteoarthritis of both knees,” Clinical Nuclear Medicine, vol. 20, no. 11, pp. 973–975, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Solanki, D. J. Li, A. Wong, R. W. Barber, E. P. Wraight, and C. B. Sampson, “Stabilization and multidose use of exametazime for cerebral perfusion studies,” Nuclear Medicine Communications, vol. 15, no. 9, pp. 718–722, 1994. View at Google Scholar · View at Scopus
  65. J. Booij, J. D. Speelman, M. W. I. M. Horstink, and E. C. Wolters, “The clinical benefit of imaging striatal dopamine transporters with [I123] FP-CIT SPET in differentiating patients with presynaptic parkinsonism from other forms of parkinsonism,” European Journal of Nuclear Medicine, vol. 28, no. 3, pp. 266–272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Lorberboym, R. Djaldetti, E. Melamed, M. Sadeh, and Y. Lampl, “I123-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism,” Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1688–1693, 2004. View at Google Scholar · View at Scopus
  67. J. Lavalaye, J. Booij, L. Reneman, J. B. A. Habraken, and E. A. Van Royen, “Effect of age and gender on dopamine transporter imaging with [I123]FP-CIT SPET in healthy volunteers,” European Journal of Nuclear Medicine, vol. 27, no. 7, pp. 867–869, 2000. View at Google Scholar · View at Scopus
  68. A. Constantinesco, P. Choquet, L. Monassier, V. Israel-Jost, and L. Mertz, “Assessment of left ventricular perfusion, volumes, and motion in mice using pinhole gated SPECT,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 1005–1011, 2005. View at Google Scholar · View at Scopus
  69. B. M. W. Tsui and D. L. Kraitchman, “Recent advances in small-animal cardiovascular imaging,” Journal of Nuclear Medicine, vol. 50, no. 5, pp. 667–670, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. P. D. Acton and H. F. Kung, “Small animal imaging with high resolution single photon emission tomography,” Nuclear Medicine and Biology, vol. 30, no. 8, pp. 889–895, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. Z. Liu, G. A. Kastis, G. D. Stevenson et al., “Quantitative analysis of acute myocardial infarct in rat hearts with ischemia-reperfusion using a high-resolution stationary SPECT system,” Journal of Nuclear Medicine, vol. 43, no. 7, pp. 933–939, 2002. View at Google Scholar · View at Scopus
  72. C. Vanhove, T. Lahoutte, M. Defrise, A. Bossuyt, and P. R. Franken, “Reproducibility of left ventricular volume and ejection fraction measurements in rat using pinhole gated SPECT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 2, pp. 211–220, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. A. Constantinesco, P. Choquet, L. Monassier, V. Israel-Jost, and L. Mertz, “Assessment of left ventricular perfusion, volumes, and motion in mice using pinhole gated SPECT,” Journal of Nuclear Medicine, vol. 46, no. 6, pp. 1005–1011, 2005. View at Google Scholar · View at Scopus
  74. Z. Liu, H. H. Barrett, G. D. Stevenson et al., “High-resolution imaging with T99mc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion,” Journal of Nuclear Medicine, vol. 45, no. 7, pp. 1251–1259, 2004. View at Google Scholar · View at Scopus
  75. P. M. Kang and S. Izumo, “Apoptosis and heart failure: a critical review of the literature,” Circulation Research, vol. 86, no. 11, pp. 1107–1113, 2000. View at Google Scholar · View at Scopus
  76. D. F. Meoli, M. M. Sadeghi, S. Krassilnikova et al., “Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction,” Journal of Clinical Investigation, vol. 113, no. 12, pp. 1684–1691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. F. D. Kolodgie, A. Petrov, R. Virmani et al., “Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque,” Circulation, vol. 108, no. 25, pp. 3134–3139, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. B. A. Khaw, Y. Tekabe, and L. L. Johnson, “Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with ZD-anti-DTPA bispecific antibody and T99mc-labeled negatively charged polymers,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 868–876, 2006. View at Google Scholar · View at Scopus
  79. J. V. Frangioni and R. J. Hajjar, “In vivo tracking of stem cells for clinical trials in cardiovascular disease,” Circulation, vol. 110, no. 21, pp. 3378–3383, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. R. Zhou, D. H. Thomas, H. Qiao et al., “In vivo detection of stem cells grafted in infarcted rat myocardium,” Journal of Nuclear Medicine, vol. 46, no. 5, pp. 816–822, 2005. View at Google Scholar · View at Scopus
  81. B. B. Chin, Y. Nakamoto, J. W. Bulte, M. F. Pittenger, R. Wahl, and D. L. Kraitchman, “111In oxide labeled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction,” Nuclear Medicine Communications, vol. 24, no. 11, pp. 1149–1154, 2003. View at Google Scholar
  82. M. Inubushi and N. Tamaki, “Radionuclide reporter gene imaging for cardiac gene therapy,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 34, supplement 1, pp. S27–S33, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. M. Rodriguez-Porcel, “In vivo imaging and monitoring of transplanted stem cells: clinical applications,” Current Cardiology Reports, vol. 12, no. 1, pp. 51–58, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. M. G. Pomper, H. Hammond, X. Yu et al., “Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models,” Cell Research, vol. 19, no. 3, pp. 370–379, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. J. Terrovitis, K. F. Kwok, R. Lautamäki et al., “Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography,” Journal of the American College of Cardiology, vol. 52, no. 20, pp. 1652–1660, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Google Scholar · View at Scopus
  87. W. P. Deng, C. C. Wu, C. C. Lee et al., “Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir,” Journal of Nuclear Medicine, vol. 47, no. 5, pp. 877–884, 2006. View at Google Scholar · View at Scopus
  88. L. E. Ponsky, E. E. Cherullo, R. Starkey, D. Nelson, D. Neumann, and C. D. Zippe, “Evaluation of preoperative ProstaScint scans in the prediction of nodal disease,” Prostate Cancer and Prostatic Diseases, vol. 5, no. 2, pp. 132–135, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  89. C. A. Foss, R. C. Mease, H. Fan et al., “Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer,” Clinical Cancer Research, vol. 11, no. 11, pp. 4022–4028, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  90. S. Sharma and M. Ebadi, “SPECT neuroimaging in translational research of CNS disorders,” Neurochemistry International, vol. 52, no. 3, pp. 352–362, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  91. S. Nikolaus, C. Antke, K. Kley, M. Beu, A. Wirrwar, and H. W. Müller, “Pretreatment with haloperidol reduces I-FP-CIT binding to the dopamine transporter in the rat striatumml: an in vivo imaging study with a dedicated small-animal SPECT camera,” Journal of Nuclear Medicine, vol. 50, no. 7, pp. 1147–1152, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. P. D. Acton, C. Hou, M.-P. Kung, K. Plössl, C. L. Keeney, and H. F. Kung, “Occupancy of dopamine D2 receptors in the mouse brain measured using ultra-high-resolution single-photon emission tomography and [I123]IBF,” European Journal of Nuclear Medicine, vol. 29, no. 11, pp. 1507–1515, 2002. View at Publisher · View at Google Scholar
  93. M. P. Kung, C. Hou, Z. P. Zhuang, A. J. Cross, D. L. Maier, and H. F. Kung, “Characterization of IMPY as a potential imaging agent for β-amyloid plaques in double transgenic PSAPP mice,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 8, pp. 1136–1145, 2004. View at Google Scholar · View at Scopus
  94. S. Nikolaus, R. Larisch, A. Wirrwar et al., “[I123]Iodobenzamide binding to the rat dopamine D receptor in competition with haloperidol and endogenous dopamine—an in vivo imaging study with a dedicated small animal SPECT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 11, pp. 1305–1310, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  95. A. Bao, W. T. Phillips, B. Goins et al., “Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection,” International Journal of Pharmaceutics, vol. 316, no. 1-2, pp. 162–169, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. D. Wang, M. Sima, R. L. Mosley et al., “Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers,” Molecular Pharmaceutics, vol. 3, no. 6, pp. 717–725, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. K. Schimmel, R. Bennink, K. De Bruin et al., “Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in rats,” Archives of Toxicology, vol. 79, no. 5, pp. 268–276, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. M. D. Devous Sr., “Single-photon emission computed tomography in neurotherapeutics,” NeuroRx, vol. 2, no. 2, pp. 237–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Van Montfrans, R. J. Bennink, K. De Bruin et al., “In vivo evaluation of 111In-labeled T-lymphocyte homing in experimental colitis,” Journal of Nuclear Medicine, vol. 45, no. 10, pp. 1759–1765, 2004. View at Google Scholar
  100. J.-L. Vanderheyden, “The use of imaging in preclinical drug development,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 4, pp. 374–381, 2009. View at Google Scholar